Mirum Pharmaceuticals Stock: The September PDUFA Is The Smallest Catalyst (NASDAQ:MIRM)

· seekingalpha.com

Mirum nears an FOP launch Sept 26; PROGRESS data, small market risks, and brelovitug Phase 3 catalysts ahead. See here for more on MIRM stock.

The calendar almost writes the bullish pitch for Mirum Pharmaceuticals ( MIRM ). One FDA decision and three Phase 3 readouts are expected before the end of the ...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI